Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes

Physiological Genomics

Volumn 25, Issue 3, 2006, Pages 435-449

  Mense, S M ^a   Sengupta, A ^a   Zhou, M ^a   Lan, C ^a   Bentsman, G ^b   Volsky, D J ^b   Zhang, L ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Hypoxic response; Microarray; Signaling pathways

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOLYTIC ENZYME; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MYC PROTEIN; PROTEIN KINASE B; PROTEIN P53;

ARTICLE; ASTROCYTE; BRAIN FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE SEQUENCE; GENETIC CODE; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING;

ALGORITHMS; ANGIOGENIC PROTEINS; ASTROCYTES; CELL HYPOXIA; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOLYSIS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-AKT; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

MAMMALIA;

EID: 33646765735     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00315.2005     Document Type: Article

References (143)

1. Acker T and Acker H. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207: 3171-3188, 2004.
2. Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F, and Landazuri MO. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22: 12-22, 2002.
3. Araque A and Perea G. Glial modulation of synaptic transmission in culture. Glia 47: 241-248, 2004.
4. Auld DS and Robitaille R. Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron 40: 389-400, 2003.
5. Barenberg P, Strahlendorf H, and Strahlendorf J. Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons. Neurosci Res 40: 245-254, 2001.
6. Bemis L, Chan DA, Finkielstein CV, Qi L, Sutphin PD, Chen X, Stenmark K, Giaccia AJ, and Zundel W. Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5. Genes Dev 18: 739-744, 2004.
7. Bilton RL and Booker GW. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur J Biochem 270: 791-798, 2003.
8. Blanchard KL, Acquaviva AM, Galson DL, and Bunn HF. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 12: 5373-5385, 1992.
9. Bliss TM, Ip M, Cheng E, Minami M, Pellerin L, Magistretti P, and Sapolsky RM. Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics. J Neurosci 24: 6202-6208, 2004.
10. + exchange in hypoxia-related acute astrocyte death. Glia 49: 143-152, 2005.
11. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P, Eyre HJ, Sutherland GR, and Adams JM. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 12: 163-168, 2001.
12. Bracken CP, Whitelaw ML, and Peet DJ. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 60: 1376-1393, 2003.
13. Burwinkel M, Riemer C, Schwarz A, Schultz J, Neidhold S, Bamme T, and Baier M. Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci 22: 497-505, 2004.
14. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39, 2002.
15. Canki M, Thai JN, Chao W, Ghorpade A, Potash MJ, and Volsky DJ. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 75: 7925-7933, 2001.
16. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, and McCubrey JA. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol 22: 469-480, 2003.
17. Chen Y and Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 23: 137-149, 2003.
18. Cherniack NS. Oxygen sensing: applications in humans. J Appl Physiol 96: 352-358, 2004.
19. Chesler M. Failure and function of intracellular pH regulation in acute hypoxic-ischemic injury of astrocytes. Glia 50: 398-406, 2005.
20. Choi WH, Ji KA, Jeon SB, Yang MS, Kim H, Min KJ, Shong M, Jou I, and Joe EH. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: suppression of interferon-gamma-induced JAK/STAT phosphorylation. Biochem Biophys Res Commun 329: 125-131, 2005.
21. Colomar A and Robitaille R. Glial modulation of synaptic transmission at the neuromuscular junction. Glia 47: 284-289, 2004.
22. 2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res 64: 9057-9061, 2004.
23. Conforti L, Kobayashi S, Beitner-Johnson D, Conrad PW, Freeman T, and Millhorn DE. Regulation of gene expression and secretory functions in oxygen-sensing pheochromocytoma cells. Respir Physiol 115: 249-260, 1999.
24. 2-sensing and hypoxia tolerance in pheochromocytoma cells. Comp Biochem Physiol B Biochem Mol Biol 128: 187-204, 2001.
25. Covello KL and Simon MC. HIFs, hypoxia, and vascular development. Curr Top Dev Biol 62: 37-54, 2004.
26. Daghman NA, Elder GE, Savage GA, Winter PC, Maxwell AP, and Lappin TR. Erythropoietin production: evidence for multiple oxygen sensing pathways. Ann Hematol 78: 275-278, 1999.
27. Denko NC, Green SL, Edwards D, and Giaccia AJ. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia. Exp Cell Res 258: 82-91, 2000.
28. Dienel GA and Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 50: 362-388, 2005.
29. Dimova EY and Kietzmann T. Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J Biol Chem 281: 2999-3005, 2006.
30. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177-182, 2004.
31. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, and Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59: 3915-398, 1999.
32. Fields RD and Stevens-Graham B. New insights into neuron-glia communication. Science 298: 556-562, 2002.
33. Galson DL, Tsuchiya T, Tendler DS, Huang LE, Ren Y, Ogura T, and Bunn HF. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol Cell Biol 15: 2135-2144, 1995.
34. Garcia-Domingo D, Leonardo E, Grandien A, Martinez P, Albar JP, Izpisua-Belmonte JC, and Martinez AC. DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development. Proc Natl Acad Sci USA 96: 7992-7997, 1999.
35. Gebicke-Haerter PJ. Microglia in neurodegeneration: molecular aspects. Microsc Res Tech 54: 47-58, 2001.
36. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401, 2001.
37. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 558: 5-30, 2004.
38. Goeddel DV. Tumor Necrosis Factor Pathway (Online). http://stke. sciencemag.org/cgi/cm/stkecm; CMP_7107, 2005.
39. Goritz C, Mauch DH, Nagler K, and Pfrieger FW. Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapseglia affair. J Physiol 96: 257-263, 2002.
40. Gu YZ, Hogenesch JB, and Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40: 519-561, 2000.
41. Gupta S, Schoer RA, Egan JE, Hannon GJ, and Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA 101: 1927-1932, 2004.
42. Hammond EM and Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331: 718-725, 2005.
43. Heales SJ, Lam AA, Duncan AJ, and Land JM. Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem Res 29: 513-519, 2004.
44. Hertz L. Intercellular metabolic compartmentation in the brain: past, present and future. Neurochem Int 45: 285-296, 2004.
45. Hori O, Matsumoto M, Kuwabara K, Maeda Y, Ueda H, Ohtsuki T, Kinoshita T, Ogawa S, Stern DM, and Kamada T. Exposure of astrocytes to hypoxia/ reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J Neurochem 66: 973-979, 1996.
46. Hu B, Wright E, Campbell L, and Blanchard KL. In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer. Mol Cell Biol 17: 851-856, 1997.
47. Huang LE, Arany Z, Livingston DM, and Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259, 1996.
48. Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, and Kim HM. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 306: 805-811, 2003.
49. Kacimi R, Chentoufi J, Honbo N, Long CS, and Karliner JS. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46: 139-150, 2000.
50. Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem 74: 115-128, 2005.
51. Kaul M, Garden GA, and Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994, 2001.
52. Kimelberg HK. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50: 389-397, 2005.
53. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003.
54. Koshiji M and Huang LE. Dynamic balancing of the dual nature of HIF-1alpha for cell survival. Cell Cycle 3: 853-854, 2004.
55. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, and Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 23: 1949-1956, 2004.
56. Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA, and Gibson SB. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22: 4734-4744, 2003.
57. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, and Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21: 1297-1310, 2001.
58. Kuwabara K, Matsumoto M, Ikeda J, Hori O, Ogawa S, Maeda Y, Kitagawa K, Imuta N, Kinoshita T, Stern DM, Yanagi H, and Kamada T. Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J Biol Chem 271: 5025-5032, 1996.
59. Kvietikova I, Wenger RH, Marti HH, and Gassmann M. The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int 51: 564-566, 1997.
60. Kvietikova I, Wenger RH, Marti HH, and Gassmann M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 23: 4542-45450, 1995.
61. Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li GC, Mendonca HL, Ryan HE, Wang Z, and Johnson RS. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol 22: 2515-2523, 2002.
62. Laderoute KR, Calaoagan JM, Knapp M, and Johnson RS. Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun. Mol Cell Biol 24: 4128-4137, 2004.
63. Lau LT and Yu AC. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma 18: 351-359, 2001.
64. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
65. Levitzki A. EGF receptor as a therapeutic target. Lung Cancer 41, Suppl 1: S9-S14, 2003.
66. Liang J and Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2: 339-345, 2003.
67. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
68. Magisretti PJ, and Ransom, 2002 BR. Astrocytes. In Davis KL, Charney D, Coyle JT, and Nemeroff C(editors). Neuropsychopharmacology: the Fifth Generation of Progress (Online). http://www.acnp.org/default.aspx?Page= 5thgenerationchapters.
69. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, and Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.
70. Mattson MP, Maudsley S, and Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 3: 445-464, 2004.
71. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, Ginouves A, Berra E, and Pouyssegur J. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 68: 971-980, 2004.
72. McClure MM, Peiffer AM, Rosen GD, and Fitch RH. Auditory processing deficits in rats with neonatal hypoxic-ischemic injury. Int J Dev Neurosci 23: 351-362, 2005.
73. Meda L, Baron P, and Scarlato G. Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol Aging 22: 885-893, 2001.
74. Meissner U, Ostreicher I, Allabauer I, Rascher W, and Dotsch J. Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun 303: 707-712, 2003.
75. Metzen E and Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. Biol Chem 385: 223-230, 2004.
76. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, and Green CJ. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275: 13613-13620, 2000.
77. Nedergaard M and Dirnagl U. Role of glial cells in cerebral ischemia. Glia 50: 281-286, 2005.
78. Nedergaard M, Ransom B, and Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26: 523-530, 2003.
79. Neubauer JA and Sunderram J. Oxygen-sensing neurons in the central nervous system. J Appl Physiol 96: 367-374, 2004.
80. Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26: 536-542, 2003.
81. Panickar KS and Norenberg MD. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50: 287-298, 2005.
82. Pearl LH and Barford D. Regulation of protein kinases in insulin, growth factor and Wnt signalling. Curr Opin Struct Biol 12: 761-767, 2002.
83. Pekny M and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50: 427-434, 2005.
84. Pekny M and Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204: 428-437, 2004.
85. Pellerin L and Magistretti PJ. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 10: 53-62, 2004.
86. Percy MJ, Mooney SM, McMullin MF, Flores A, Lappin TR, and Lee FS. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation. Mol Cancer 2: 31, 2003.
87. Perea G and Araque A. Synaptic regulation of the astrocyte calcium signal. J Neural Transm 112: 127-135, 2005.
88. Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, Belperio JA, Keane MP, and Strieter RM. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280: 22473-22481, 2005.
89. Piccini A and Malinow R. Transient oxygen-glucose deprivation induces rapid morphological changes in rat hippocampal dendrites. Neuropharmacology 41: 724-729, 2001.
90. Plum L, Schubert M, and Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16: 59-65, 2005.
91. Ransom B, Behar T, and Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci 26: 520-522, 2003.
92. Ruas JL and Poellinger L. Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin Cell Dev Biol 16: 514-522, 2005.
93. Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K, and Blagosklonny MV. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 22: 1734-1741, 2002.
94. Saltiel AR and Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 12: 65-71, 2002.
95. Scheid MP, Marignani PA, and Woodgett JR. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol Cell Biol 22: 6247-6260, 2002.
96. Scheid MP and Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 546: 108-112, 2003.
97. Schlessinger J. Epidermal Growth Factor Receptor (Online). http://stke.sciencemag.org/cgi/cm/stkecm; CMP_14987, 2005.
98. Schmid T, Zhou J, and Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 8: 423-431, 2004.
99. Schofield CJ and Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
100. Scortegagna M, Morris MA, Oktay Y, Bennett M, and Garcia JA. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 102: 1634-1640, 2003.
101. Sears RC and Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem 277: 11617-11620, 2002.
102. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 19: 176-182, 2004.
103. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
104. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, and Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci USA 88: 8725-8729, 1991.
105. Semenza GL, Nejfelt MK, Chi SM, and Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88: 5680-5684, 1991.
106. Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992.
107. Seta K, Kim HW, Ferguson T, Kim R, Pathrose P, Yuan Y, Lu G, Spicer Z, and Millhorn DE. Genomic and physiological analysis of oxygen sensitivity and hypoxia tolerance in PC12 cells. Ann NY Acad Sci 971: 379-388, 2002.
108. Seta KA, Ferguson TK, and Millhorn DE. Discovery of oxygen-responsive genes in pheochromocytoma cells. Methods Enzymol 381: 449-464, 2004.
109. Seta KA and Millhorn DE. Functional genomics approach to hypoxia signaling. J Appl Physiol 96: 765-773, 2004.
110. Seta KA, Spicer Z, Yuan Y, Lu G, and Millhorn DE. Responding to hypoxia: lessons from a model cell line. Sci STKE: RE11, 2002.
111. Seta KA, Yuan Y, Spicer Z, Lu G, Bedard J, Ferguson TK, Pathrose P, Cole-Strauss A, Kaufhold A, and Millhorn DE. The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium 36: 331-340, 2004.
112. Sharp FR and Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5: 437-448, 2004.
113. Shibahara S, Nakayama M, Kitamuro T, Udono-Fujimori R, and Takahashi K. Repression of heme oxygenase-1 expression as a defense strategy in humans. Exp Biol Med (Maywood) 228: 472-473, 2003.
114. Shulman RG, Rothman DL, Behar KL, and Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 27: 489-495, 2004.
115. Sikorski EM, Hock T, Hill-Kapturczak N, and Agarwal A. The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286: F425-F441, 2004.
116. Singh AB and Harris RC. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17: 1183-1193, 2005.
117. Slezak M and Pfrieger FW. New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 26: 531-535, 2003.
118. Spicer Z and Millhorn DE. Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model. Endocr Pathol 14: 277-291, 2003.
119. Takahashi S, Takahashi Y, Yoshimi T, and Miura T. Oxygen tension regulates heme oxygenase-1 gene expression in mammalian cell lines. Cell Biochem Funct 16: 183-193, 1998.
120. Tamatani M, Matsuyama T, Yamaguchi A, Mitsuda N, Tsukamoto Y, Taniguchi M, Che YH, Ozawa K, Hori O, Nishimura H, Yamashita A, Okabe M, Yanagi H, Stern DM, Ogawa S, and Tohyama M. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med 7: 317-323, 2001.
121. Tamm M, Bihl M, Eickelberg O, Stulz P, Perruchoud AP, and Roth M. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol 19: 653-661, 1998.
122. Ten VS and Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 8: 242-250, 2002.
123. To KK, Koshiji M, Hammer S, and Huang LE. Genetic instability: the dark side of the hypoxic response. Cell Cycle 4: 881-882, 2005.
124. Trendelenburg G and Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50: 307-320, 2005.
125. Vermeulen K, Berneman ZN, and Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003.
126. Volterra A and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6: 626-640, 2005.
127. Wang GL and Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268: 21513-21518, 1993.
128. Wang GL and Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90: 4304-4308, 1993.
129. Wang GL and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
130. Wang Z, Trillo-Pazos G, Kim SY, Canki M, Morgello S, Sharer LR, Gelbard HA, Su ZZ, Kang DC, Brooks AI, Fisher PB, and Volsky DJ. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 10, Suppl 1: 25-32, 2004.
131. Ward JP, Snetkov VA, and Aaronson PI. Calcium, mitochondria and oxygen sensing in the pulmonary circulation. Cell Calcium 36: 209-220, 2004.
132. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, and Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem 253: 771-777, 1998.
133. White MF. Insulin Signaling Pathway (Online). http://stke.sciencemag.org/ cgi/cm/stkecm; CMP_12069, 2005.
134. Wong RW and Guillaud L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15: 147-156, 2004.
135. Yang ZZ and Zou AP. Transcriptional regulation of heme oxygenases by HIF-1α in renal medullary interstitial cells. Am J Physiol Renal Physiol 281: F900-F908, 2001.
136. Yasuda M, Han JW, Dionne CA, Boyd JM, and Chinnadurai G. BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res 59: 533-537, 1999.
137. Yim S, Choi SM, Choi Y, Lee N, Chung J, and Park H. Insulin and hypoxia share common target genes but not the hypoxia-inducible factor-1alpha. J Biol Chem 278: 38260-38268, 2003.
138. Zagorska A and Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 51: 563-585, 2004.
139. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, and Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 17: 5085-5094, 1998.
140. Zhang SX, Gozal D, Sachleben, LR Jr, Rane M, Klein JB, and Gozal E. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-β receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. FASEB J 17: 1709-1711, 2003.
141. Zhang W and Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18, 2002.
142. Zhu H, Jackson T, and Bunn HF. Detecting and responding to hypoxia. Nephrol Dial Transplant 17, Suppl 1: 3-7, 2002.
143. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE: PE4, 2005.